Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin for Erectile Dysfunction
NCT00382161Phase 3Withdrawn
- Sponsor
- Saarland University Medical Center
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Fluvastatin First with Placebo First (2 arms). Primary endpoint: Penile blood flow (peak systolic velocity, resistance index, pulsatility index) at 8 weeks. Planned start Oct 2006; status: withdrawn.
02
Drugs
fluvastatin
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00382161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382161.